FOXO1 plays an important role in enhanced microvascular cell apoptosis and microvascular cell loss in type 1 and type 2 diabetic rats

Diabetes

Volumn 58, Issue 4, 2009, Pages 917-925

  Behl, Yugal ^a   Krothapalli, Padmaja ^a   Desta, Tesfahun ^a   Roy, Sayon ^b   Graves, Dana T ^c  

^a BOSTON UNIVERSITY   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 7; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; INSULIN; MESSENGER RNA; NUCLEAR PROTEIN; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR FKHR; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL LOSS; CONTROLLED STUDY; DIABETIC RETINOPATHY; ENDOTHELIUM CELL; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PERICYTE; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; RAT; RETINA BLOOD VESSEL; STREPTOZOCIN DIABETES; ZUCKER DIABETIC FATTY RAT;

ANIMALS; APOPTOSIS; CELL NUCLEUS; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; ENDOTHELIUM, VASCULAR; FORKHEAD TRANSCRIPTION FACTORS; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; MICROCIRCULATION; NERVE TISSUE PROTEINS; POLYMERASE CHAIN REACTION; RATS; RATS, SPRAGUE-DAWLEY; RATS, ZUCKER; RETINAL VESSELS; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 64649104157     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db08-0537     Document Type: Article

References (34)

1. Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047-1053, 2004
2. Fong DS, Aiello L, Gardner TW, King GL, Blankenship G, Cavallerano JD, Ferris FL 3rd, Klein R: Retinopathy in diabetes. Diabetes Care 27 (Suppl. 1):S84-S87, 2004
3. Mizutani M, Kern TS, Lorenzi M: Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy. J Clin Invest 97:2883-2890, 1996
4. Hammes HP: Pericytes and the pathogenesis of diabetic retinopathy. Horm Metab Res 37 (Suppl. 1):39-43, 2005
5. Benjamin LE: Glucose, VEGF-A, and diabetic complications. Am, J Pathol 158:1181-1184, 2001
6. Kramerov AA, Saghizadeh M, Pan H, Kabosova A, Montenarh M, Ahmed K, Penn JS, Chan CK, Hinton DR, Grant MB, Ljubimov AV: Expression of protein kinase CK2 in astroglial cells of normal and neovascularized retina. Am J Pathol 168:1722-1736, 2006
7. Yatoh S, Mizutani M, Yokoo T, Kozawa T, Sone H, Toyoshima H, Suzuki S, Shimano H, Kawakami Y, Okuda Y, Yamada N: Antioxidants and an inhibitor of advanced glycation ameliorate death of retinal microvascular cells in diabetic retinopathy. Diabetes Metab Res Rev 22:38-45, 2006
8. Reiter CE, Wu X, Sandirasegarane L, Nakamura M, Gilbert KA, Singh RS, Fort PE, Antonetti DA, Gardner TW: Diabetes reduces basal retinal insulin receptor signaling: reversal with systemic and local insulin. Diabetes 55:1148-1156, 2006
9. Accili D, Arden KC: FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell 117:421-426, 2004
10. Furukawa-Hibi Y, Kobayashi Y, Chen C, Motoyama N: FOXO transcription factors in cell-cycle regulation and the response to oxidative stress. Antioxid Redox Signal 5-6:752-760, 2005
11. Burgering BM, Kops GJ: Cell cycle and death control: long live Forkheads. Trends Biochem Sci 27:352-360, 2002
12. Matsumoto M, Han S, Kitamura T, Accili D: Dual role of transcription factor FoxO1 in controlling hepatic insulin sensitivity and lipid metabolism. J Clin Invest 116:2464-2472, 2006
13. Potente M, Urbich C, Sasaki K, Hofmann WK, Heeschen C, Aicher A, Kollipara R, DePinho RA, Zeiher AM, Dimmeler S: Involvement of Foxo transcription factors in angiogenesis and postnatal neovascularization. J Clin Invest 115:2382-2392, 2005
14. Stitt TN, Drujan D, Clarke BA, Panaro F, Timofeyva Y, Kline WO, Gonzalez M, Yancopoulos GD, Glass DJ: The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol Cell 14:395-403, 2004
15. Nakae J, Kitamura T, Kitamura Y, Bigss Wr, Arden K, Accili D: The forkhead transcription factor Foxo1 regulates adipocyte differentiation. Dev Cell 4:119-129, 2003
16. Behl Y, Krothapalli P, Desta T, DiPiazza A, Roy S, Graves DT: Diabetes-enhanced tumor necrosis factor-alpha production promotes apoptosis and the loss of retinal microvascular cells in type 1 and type 2 models of diabetic retinopathy. Am J Pathol 172:1411-1418, 2008
17. Oshitari T, Polewski P, Chadda M, Li A-F, Sato T, Roy S: Effect of combined antisense oligonucleotides against high-glucose- and diabetes-induced overexpression of extracellular matrix components and increased vascular permeability. Diabetes 55:86-92, 2006
18. Edwards CK 3rd, Martin SW, Seely J, Kinstler O, Buckel S, Bendele AM, Ellen Cosenza M, Feige U, Kohno T: Design of PEGylated soluble tumor necrosis factor receptor type I (PEG sTNF-RI) for chronic inflammatory diseases. Adv Drug Deliv Rev 55:1315-1336, 2003
19. Roy S, Roth T: Proliferative effect of high glucose is modulated by antisense oligonucleotides against fibronectin in rat endothelial cells. Diabetologia 40:1011-1017, 1997
20. Alikhani M, Alikhani Z, Graves DT: FOXO1 functions as a master switch that regulates gene expression necessary for tumor necrosis factor- induced fibroblast apoptosis. J Biol Chem 280:12096-12102, 2005
21. Alikhani M, Alikhani Z, He H, Liu R, Popek BI, Graves DT: Lipopolysac-charides indirectly stimulate apoptosis and global induction of apoptotic genes in fibroblasts. J Biol Chem 278:52901-52908, 2003
22. Bartlett DW, Davis ME: Insights into the kinetics of siRNA-mediated gene silencing from live-cell and live-animal bioluminescent imaging. Nucleic Acid Res 34:322-333, 2006
23. Roy S, Sato T, Paryani G, Kao R: Downregulation of fibronectin overex- pression reduces basement membrane thickening and vascular lesions in retinas of galactose-fed rats. Diabetes 52:1229-1234, 2003
24. Gary DJ, Puri N, Won YY: Polymer-based siRNA delivery: perspectives on the fundamental and phenomenological distinctions from polymer-based DNA delivery. J Control Release 121:64-73, 2007
25. Holz GG, Chepurny OG: Diabetes outfoxed by GLP-1? Sci STKE 2005:pe2, 2005
26. Barber AJ, Antonetti DA, Kern TS, Reiter CE, Soans RS, Krady JK, Levison SW, Gardner TW, Bronson SK: The Ins2Akita mouse as a model of early retinal complications in diabetes. Invest Ophthalmol Vis Sci 46:2210-2218, 2005
27. Kowluru RA, Chan PS: Oxidative stress and diabetic retinopathy. Exp Diabetes Res 2007:43603, 2007
28. Clark PR, Manes TD, Pober JS, Kluger MS: Increased ICAM-1 expression causes endothelial cell leakiness, cytoskeletal reorganization and junctional alterations. J Invest Dermatol 127:762-774, 2007
29. Masuzawa K, Goto K, Jesmin S, Maeda S, Miyauchi T, Kaji Y, Oshika T, Hori S: An endothelin type A receptor antagonist reverses upregulated VEGF and ICAM-1 levels in streptozotocin-induced diabetic rat retina. Curr Eye Res 31:79-89, 2006
30. Lorenzi M, Gerhardinger C: Early cellular and molecular changes induced by diabetes in the retina. Diabetologia 44:791-804, 2001
31. Daly C, Wong V, Burova E, Wei Y, Zabski S, Griffiths J, Lai KM, Lin HC, Ioffe E, Yancopoulos GD, Rudge JS: Angiopoietin-1 modulates endothelial cell function and gene expression via the transcription factor FKHR (FOXO1). Genes Dev 18:1060-1071, 2004
32. van der Vos KE, Coffer PJ: FOXO-binding partners: it takes two to tango. Oncogene 27:2289-9933, 2008
33. Sekine K, Chen YR, Kojima N, Ogata K, Fukamizu A, Miyajima A: FOXO1 links insulin signaling to C/EBPalpha and regulates gluconeogenesis during liver development. EMBO J 26:3607-3615, 2007
34. Zhang L, Wang C: Identification of a new class of PAX3-FKHR target promoters: a role of the Pax3 paired box DNA binding domain. Oncogene 26:1595-605, 2007